Digital Healthcare And Aging Trends Will Expand Opportunities

AnalystHighTarget

Not Invested

Consensus Narrative from 3 Analysts

Published

24 Aug 25

Updated

24 Aug 25

AnalystHighTarget's Fair Value

DKK 39.10

17.1% undervalued

24 Aug

DKK 32.40

7.6%

2.5%

7.6%

2.5%

Author's Valuation

DKK 39.1

17.1% undervalued

AnalystHighTarget Fair Value

Narrative

Updates0

AnalystHighTarget Fair Value

DKK 39.1

17.1% undervalued

Future estimation in

% p.a.

Decrease

Increase

Current revenue growth rate

8.01%

Medical Equipment revenue growth rate

0.44%

Risk Level (Discount Rate)

Our default considers factors like the company's size, volatility, profitablity and country of operation.

Decrease

Increase

Current discount rate

7.21%

Calculation

US$121.88m

Earnings '28

26.27x

PE Ratio '28

US$3.20b

Market Cap '28

US$3.20b

Market Cap '28

423.62m

No. shares '28

US$7.56

Share Price '28

US$7.56 Share Price '28

Discounted to 2025 @ 7.22% p.a.

US$6.13

Fair Value '25

US$6.13 Fair Value '25

Converted to DKK @ 6.3692 USD/DKK Exchange Rate

DKK 39.04

Fair Value '25